Product Information
ATROPINE 1% EYE DROP is a generic product labeled by Somerset Therapeutics, LLC, priced at $4.1619 per ML under NDC 70069058301. Its NADAC has been published 61 times since Aug 6, 2025.
FDA first approved this application on Jul 1, 2024. Its Orange Book therapeutic-equivalence code is AT1.
Strength
10 mg/mL
Manufacturer
Somerset Therapeutics, LLCNDC
70069058301
Classification
Generic
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Effective Date
9/23/2026
Active Ingredients
ATROPINE SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA215618FDA Approved
7/1/2024
TE Code
AT1
On Market Since
2/12/2025
Pharmacological Classes
Price Statistics
The NADAC for ATROPINE 1% EYE DROP has been published 61 times since Aug 6, 2025, and over the history we have for it it has declined 39.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.1619 per ML |
|---|---|
| All-time high | $6.8246 (Aug 13, 2025) |
| All-time low | $3.8514 (Jul 22, 2026) |
| 52-week high | $6.6272 |
| 52-week low | $3.8514 |
| Median price | $4.5911 |
| Average price | $4.9412 |
| Largest weekly change | -13.6% (Oct 22, 2025) |
| Weeks tracked | 61 |
| Tracking since | Aug 6, 2025 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Somerset Therapeutics, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Atropine sulfate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Anticholinergic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ATROPINE 1% EYE DROP?
The current National Average Drug Acquisition Cost (NADAC) for ATROPINE 1% EYE DROP, manufactured by Somerset Therapeutics, LLC, is $4.1619 per ML (NDC 70069058301), effective Sep 30, 2026.
How has the price of ATROPINE 1% EYE DROP changed over time?
Over the history we have for it, the NADAC for ATROPINE 1% EYE DROP has declined 39.0%. It has been tracked across 61 weekly CMS publications since Aug 6, 2025.
What are the highest and lowest recorded NADAC prices for ATROPINE 1% EYE DROP?
Since Aug 6, 2025, the NADAC for ATROPINE 1% EYE DROP has ranged from a low of $3.8514 (Jul 22, 2026) to a high of $6.8246 (Aug 13, 2025), with a median of $4.5911 per ML.
Are there cheaper alternatives to ATROPINE 1% EYE DROP?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as ATROPINE 1% EYE DROP in a comparable dosage form, but none are currently priced below it.
Who manufactures ATROPINE 1% EYE DROP?
ATROPINE 1% EYE DROP (NDC 70069058301) is labeled by Somerset Therapeutics, LLC, and CMS classifies it as a generic product.